Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
A new peer-reviewed study based on data from nearly 2M individuals highlights a wide range of clinical benefits and risks, ...
Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may ... sleep disturbances and non-infectious gastroenteritis, which is inflammation of the digestive tract which ...